Truth Initiative Partners with Pennsylvania's Office of Attorney General to Provide Prescription Drug Safety Course, Powered by EVERFI from Blackbaud
WASHINGTON and CHARLESTON, S.C., April 24, 2024 /PRNewswire/ -- Truth Initiative, the organization behind truth®, the nationally recognized, proven-effective youth tobacco and opioid prevention public education campaigns, and EVERFI® from Blackbaud®, the leader in powering social impact through education, are teaming up once again to deliver Prescription Drug Safety: Know the truth. The Pennsylvania Office of the Attorney General is supporting this important resource through its Community Drug Abuse Prevention (CDAP) grant program (made possible by the Substance Abuse Education and Demand Reduction Fund) to deliver the innovative digital course to students in grades 8-12 across the Commonwealth. The course educates students about the dangers of misusing prescription drugs, including fentanyl, exploring the impact misuse can have on their physical and mental health, relationships, communities — and their futures.
- Truth Initiative and EVERFI will work with educators, administrators, and district-level officials to implement the program in line with local context and relevant themes.
- Originally released in 2017, Prescription Drug Safety: Know the truth guides students through real-world scenarios delivered in Truth Initiative's authentic peer-to-peer voice.
- A recent independent study found that EVERFI's Prescription Drug Safety course has a positive and lasting impact on students' knowledge, attitudes, and behaviors regarding safe prescription drug use.
- Prescription Drug Safety: Know the truth is the latest collaboration between Truth Initiative and EVERFI and is available to schools at no cost.